• Energy Research
• 12. Responsible consumption close
• 3. Good health close

Abstract The combination of biomass gasification with fuel cells, especially high temperature Solid Oxide Fuel Cells (SOFCs) promises sustainable and highly efficient (decentralized and modular) energy conversion systems. This review encompasses the components of biomass integrated gasification–SOFC technology including biomass characteristics, the thermochemical conversion in gasifiers and the factors affecting the gasification process, the cleaning technologies for raw producer gas and its conditioning and finally the integration of gasifier with SOFCs. The influence of impurities present in biomass producer gas such as particulates, tar, H 2 S, HCl and alkali compounds based on recent experimental studies and their tolerance limits towards SOFCs are presented. Even though analysis based on the probable tolerance limits of impurities towards SOFCs and a comprehensive overview of the cleaning technologies for producer gas impurities indicate that producer gas cleaning at various temperatures using current technologies to meet SOFC requirements is possible, more experimental studies are still needed to acquire the detailed information on the tolerance limits of impurities for SOFCs. The recent theoretical modeling and experimental studies of biomass integrated gasification–SOFC systems are also presented.

Abstract The combination of biomass gasification with fuel cells, especially high temperature Solid Oxide Fuel Cells (SOFCs) promises sustainable and highly efficient (decentralized and modular) energy conversion systems. This review encompasses the components of biomass integrated gasification–SOFC technology including biomass characteristics, the thermochemical conversion in gasifiers and the factors affecting the gasification process, the cleaning technologies for raw producer gas and its conditioning and finally the integration of gasifier with SOFCs. The influence of impurities present in biomass producer gas such as particulates, tar, H 2 S, HCl and alkali compounds based on recent experimental studies and their tolerance limits towards SOFCs are presented. Even though analysis based on the probable tolerance limits of impurities towards SOFCs and a comprehensive overview of the cleaning technologies for producer gas impurities indicate that producer gas cleaning at various temperatures using current technologies to meet SOFC requirements is possible, more experimental studies are still needed to acquire the detailed information on the tolerance limits of impurities for SOFCs. The recent theoretical modeling and experimental studies of biomass integrated gasification–SOFC systems are also presented.

If femoral blood is not available at autopsy, toxicological analyses, in particular blood ethanol measurements, are carried out on cardiac blood. This is known to be subject to major redistribution. We aimed to determine whether subclavian blood can be equated with a peripheral blood sample and could be used if femoral blood is not available. The study was based on 50 medicolegal autopsies in which we compared ethanol concentrations between subclavian blood, the different heart blood compartments (right and left cardiac blood), and femoral blood. Mechanisms that could lead to variations in concentration, i.e., postmortem redistribution and/or endogenous production, were also taken into account in interpreting the results. Ethanol concentrations were determined by headspace gas chromatography with a flame ionization detector. In each case, we recorded the circumstances of death, resuscitation attempts if any, degree of putrefaction, chest or abdominal trauma, and/or inhalation of gastric fluid in the airways. Ethanol concentrations in subclavian blood were found to be close to those in peripheral blood (p = 0.948) and were not influenced by the degree of putrefaction (r = 0.017, p = 0.904), gastric ethanol concentration (r = -0.011, p = 0.940), inhalation of gastric contents in the airways (p = 0.461), or cardiac resuscitation attempts (p = 0.368). We discuss the possible explanations for these findings and stress the value of sampling subclavian blood when femoral blood is not obtainable at autopsy.

If femoral blood is not available at autopsy, toxicological analyses, in particular blood ethanol measurements, are carried out on cardiac blood. This is known to be subject to major redistribution. We aimed to determine whether subclavian blood can be equated with a peripheral blood sample and could be used if femoral blood is not available. The study was based on 50 medicolegal autopsies in which we compared ethanol concentrations between subclavian blood, the different heart blood compartments (right and left cardiac blood), and femoral blood. Mechanisms that could lead to variations in concentration, i.e., postmortem redistribution and/or endogenous production, were also taken into account in interpreting the results. Ethanol concentrations were determined by headspace gas chromatography with a flame ionization detector. In each case, we recorded the circumstances of death, resuscitation attempts if any, degree of putrefaction, chest or abdominal trauma, and/or inhalation of gastric fluid in the airways. Ethanol concentrations in subclavian blood were found to be close to those in peripheral blood (p = 0.948) and were not influenced by the degree of putrefaction (r = 0.017, p = 0.904), gastric ethanol concentration (r = -0.011, p = 0.940), inhalation of gastric contents in the airways (p = 0.461), or cardiac resuscitation attempts (p = 0.368). We discuss the possible explanations for these findings and stress the value of sampling subclavian blood when femoral blood is not obtainable at autopsy.

One of the major challenges engineers face when developing military test systems is balancing the life cycle mismatch of test equipment that's commonly deployed for 20+ years with the shorter life cycle of commercial-off-the-shelf (COTS) components often used in those systems. To ensure long term supportability of these systems, it is important to plan for obsolescence issues starting in the product development phase and continuing through the sustaining state to end of life.

One of the major challenges engineers face when developing military test systems is balancing the life cycle mismatch of test equipment that's commonly deployed for 20+ years with the shorter life cycle of commercial-off-the-shelf (COTS) components often used in those systems. To ensure long term supportability of these systems, it is important to plan for obsolescence issues starting in the product development phase and continuing through the sustaining state to end of life.

1. The gastroprotective activity of two azomethine prodrugs of (R)-alpha-methylhistamine was examined in lesions induced by absolute ethanol (1 ml/rat intragastrically for 1 h). 2. Pretreatment with (R)-alpha-methylhistamine as well as with the prodrugs (30 and 100 mg/kg intragastrically [IG]) significantly reduced macroscopically visible lesions caused by ethanol, with protection being almost complete at 100 mg/kg. 3. Histologically, in rats pretreated with the three compounds at a dose of 100 mg/kg, the evidence of damage was rare, with the appearance of gastric mucosa being similar in the different groups. 4. Present results are suggestive of a local component in the protective activity of (R)-alpha-methylhistamine.

1. The gastroprotective activity of two azomethine prodrugs of (R)-alpha-methylhistamine was examined in lesions induced by absolute ethanol (1 ml/rat intragastrically for 1 h). 2. Pretreatment with (R)-alpha-methylhistamine as well as with the prodrugs (30 and 100 mg/kg intragastrically [IG]) significantly reduced macroscopically visible lesions caused by ethanol, with protection being almost complete at 100 mg/kg. 3. Histologically, in rats pretreated with the three compounds at a dose of 100 mg/kg, the evidence of damage was rare, with the appearance of gastric mucosa being similar in the different groups. 4. Present results are suggestive of a local component in the protective activity of (R)-alpha-methylhistamine.